Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

R-CHOP Versus R-FC Followed by Maintenance with Rituximab Versus Interferon-Alfa: Outcome of the First Randomized Trial for Elderly Patients with Mantle Cell Lymphoma

J.C. Kluin-Nelemans, E. Hoster, J. Walewski, MD, S. Stilgenbauer, M.D., C. H. Geisler, C. Gisselbrecht, MD, U. Vehling-Kaiser, MD, J. K. Doorduijn, MD, M. Trneny, MD, B. Coiffier, MD, R. Forstpointner, MD, H. Tilly, MD, L. Kanz, MD, M. Szymczyk, MD, O. Hermine, MD, PhD, W. Klapper, MD, W. Hiddemann, MD, M. Unterhalt, PhD, M. H. Dreyling, MD

Blood (2011) 118 (21): 439.

https://doi.org/10.1182/blood.V118.21.439.439

Published: 2011

Journal Articles

MYC + Diffuse Large B Cell Lymphomas (DLBCL) Treated in Randomized Prospective Salvage Therapy, RICE or RDHAP Followed by BEAM Plus Autologous Stem Cell Transplantation (ASCT). A BioCORAL Report

Wendy Cuccuini, Josette Briere, Nicolas Mounier, MD, PhD, Hans-Ullrich Voelker, Andreas Rosenwald, MD, Christer Sundstrom, MD, PhD, Sergio Cogliatti, Dominique Bron, MD, Edouard Hirchaud, Jean Soulier, MD, Philippe Gaulard, MD, Remi Houlgatte, C. Gisselbrecht, MD, Catherine Thieblemont, MD

Blood (2011) 118 (21): 594.

https://doi.org/10.1182/blood.V118.21.594.594

Published: 2011

Journal Articles

Long Term Follow-up of the GELF86 French and Belgian Trials: Complete Remission after First Line Treatment with Conventional Chemotherapy in Newly Diagnosed Follicular Lymphoma Patients Correlates with Prolonged Overall Survival Compared with Partial Remission

E. Bachy, P. Brice, M. Fournier, H. Tilly, C. Haioun, N. Brousse, S. Le Gouil, A. Bosly, B. Coiffier, C. Gisselbrecht, P. Solal-Celigny, G. Salles

Blood (2008) 112 (11): 2590.

https://doi.org/10.1182/blood.V112.11.2590.2590

Published: 2008

Journal Articles

The Role of Autologous Stem Cell Transplantation (ASCT) in Patients with Advanced Waldenström’s Macroglobulinemia.

Charalampia Kyriakou, MD, C. Canals, MD, A. Sureda, MD, G. Taghipour, C. Gisselbrecht, MD, P. Mazza, MD, E. Montserrat, MD, N. Niederwieser, MD, K. Indrak, MD, A. Kolbe, MD, P. Biron, MD, A. Levis, MD, A. Goldstone, MD, N. Schmitz, MD

Blood (2007) 110 (11): 941.

https://doi.org/10.1182/blood.V110.11.941.941

Published: 2007

Journal Articles

Safety of Prophylactic Use of Darbepoetin Alfa in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP 14 or R-CHOP21: Preliminary Results of the LNH03-6B Randomized GELA Study.

R. Delarue, N. Mounier, C. Haioun, B. Coiffier, C. Gisselbrecht, H. Ghesquieres, P. Lederlin, M. Blanc, C. Recher, O. Hermine, F. Reyes, H. Tilly, A. Bosly

Blood (2006) 108 (11): 2436.

https://doi.org/10.1182/blood.V108.11.2436.2436

Published: 2006

Journal Articles

No Role for Chemoradiotherapy When Compared with Chemotherapy Alone in Elderly Patients with Localized Low Risk Aggressive Lymphoma: Final Results of the LNH93-4 GELA Study.

Georges Fillet, C. Bonnet, N. Mounier, G. Ganem, T. Molina, C. Thieblemont, C. Fermé, B. Quesnel, C. Martin, C. Gisselbrecht, H. Tilly, F. Reyes

Blood (2005) 106 (11): 15.

https://doi.org/10.1182/blood.V106.11.15.15

Published: 2005

Journal Articles

Intensive therapy with peripheral blood progenitor cell transplantation in 60 patients with poor-prognosis follicular lymphoma

Y Bastion, P Brice, C Haioun, A Sonet, G Salles, JP Marolleau, D Espinouse, F Reyes, C Gisselbrecht, B Coiffier

Blood (1995) 86 (8): 3257–3262.

https://doi.org/10.1182/blood.V86.8.3257.3257

Published: 1995

Journal Articles

Administration of an anti-interleukin-6 monoclonal antibody to patients with acquired immunodeficiency syndrome and lymphoma: effect on lymphoma growth and on B clinical symptoms

D Emilie, J Wijdenes, C Gisselbrecht, B Jarrousse, E Billaud, JY Blay, J Gabarre, JP Gaillard, J Brochier, M Raphael

Blood (1994) 84 (8): 2472–2479.

https://doi.org/10.1182/blood.V84.8.2472.2472

Published: 1994

Journal Articles

Interleukin-2 treatment in lymphoma: a phase II multicenter study [see comments]

C Gisselbrecht, D Maraninchi, JL Pico, N Milpied, B Coiffier, M Divine, P Tiberghien, A Bosly, H Tilly, O Boulat

Blood (1994) 83 (8): 2081–2085.

https://doi.org/10.1182/blood.V83.8.2081.2081

Published: 1994

Journal Articles

Interleukin-6 production in high-grade B lymphomas: correlation with the presence of malignant immunoblasts in acquired immunodeficiency syndrome and in human immunodeficiency virus-seronegative patients

D Emilie, J Coumbaras, M Raphael, O Devergne, HJ Delecluse, C Gisselbrecht, JF Michiels, J Van Damme, T Taga, T Kishimoto

Blood (1992) 80 (2): 498–504.

https://doi.org/10.1182/blood.V80.2.498.498

Published: 1992

NARROW

R-CHOP Versus R-FC Followed by Maintenance with Rituximab Versus Interferon-Alfa: Outcome of the First Randomized Trial for Elderly Patients with Mantle Cell Lymphoma

MYC + Diffuse Large B Cell Lymphomas (DLBCL) Treated in Randomized Prospective Salvage Therapy, RICE or RDHAP Followed by BEAM Plus Autologous Stem Cell Transplantation (ASCT). A BioCORAL Report

Long Term Follow-up of the GELF86 French and Belgian Trials: Complete Remission after First Line Treatment with Conventional Chemotherapy in Newly Diagnosed Follicular Lymphoma Patients Correlates with Prolonged Overall Survival Compared with Partial Remission

The Role of Autologous Stem Cell Transplantation (ASCT) in Patients with Advanced Waldenström’s Macroglobulinemia.

Safety of Prophylactic Use of Darbepoetin Alfa in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP 14 or R-CHOP21: Preliminary Results of the LNH03-6B Randomized GELA Study.

No Role for Chemoradiotherapy When Compared with Chemotherapy Alone in Elderly Patients with Localized Low Risk Aggressive Lymphoma: Final Results of the LNH93-4 GELA Study.

Intensive therapy with peripheral blood progenitor cell transplantation in 60 patients with poor-prognosis follicular lymphoma

Administration of an anti-interleukin-6 monoclonal antibody to patients with acquired immunodeficiency syndrome and lymphoma: effect on lymphoma growth and on B clinical symptoms

Interleukin-2 treatment in lymphoma: a phase II multicenter study [see comments]

Interleukin-6 production in high-grade B lymphomas: correlation with the presence of malignant immunoblasts in acquired immunodeficiency syndrome and in human immunodeficiency virus-seronegative patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only